AR104200A1 - Carboximetilcisteina para tratamiento tópico de estrías - Google Patents

Carboximetilcisteina para tratamiento tópico de estrías

Info

Publication number
AR104200A1
AR104200A1 ARP160100935A ARP160100935A AR104200A1 AR 104200 A1 AR104200 A1 AR 104200A1 AR P160100935 A ARP160100935 A AR P160100935A AR P160100935 A ARP160100935 A AR P160100935A AR 104200 A1 AR104200 A1 AR 104200A1
Authority
AR
Argentina
Prior art keywords
topical
carboximethylcisteine
stress treatment
treatment
stress
Prior art date
Application number
ARP160100935A
Other languages
English (en)
Inventor
Iob Giuliana
Scarci Francesco
Mailland Federico
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of AR104200A1 publication Critical patent/AR104200A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Reivindicación 1: Una composición tópica para el tratamiento de estrías, caracterizada porque comprende carboximetilcisteína y uno o más excipientes fisiológicamente aceptables.
ARP160100935A 2015-04-16 2016-04-07 Carboximetilcisteina para tratamiento tópico de estrías AR104200A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15163871.5A EP3081212A1 (en) 2015-04-16 2015-04-16 Carboxymethylcysteine for topical treatment of stretch marks

Publications (1)

Publication Number Publication Date
AR104200A1 true AR104200A1 (es) 2017-07-05

Family

ID=52875610

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100935A AR104200A1 (es) 2015-04-16 2016-04-07 Carboximetilcisteina para tratamiento tópico de estrías

Country Status (4)

Country Link
EP (1) EP3081212A1 (es)
AR (1) AR104200A1 (es)
TW (1) TW201642846A (es)
WO (1) WO2016166082A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3791852A1 (en) * 2019-09-13 2021-03-17 Infinitec Activos S.L. Sub-microparticles of silica conjugated with cysteine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1139379C (zh) * 2000-03-15 2004-02-25 王有仁 加速创伤和烧伤愈合的羧甲司坦组合物
EP1886676A1 (en) 2006-08-09 2008-02-13 Polichem S.A. Compositions with enhanced elasticizing activity
US8673328B2 (en) * 2010-04-11 2014-03-18 Agnes Mwangi Blomberg Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, stearic acid, magnesium sulfate, zinc oxide, glycerin, and water

Also Published As

Publication number Publication date
TW201642846A (zh) 2016-12-16
EP3081212A1 (en) 2016-10-19
WO2016166082A1 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
CY1123845T1 (el) Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων
CL2018003316A1 (es) Compuestos para la inhibición de k-ras y para el tratamiento del cáncer. (divisional solicitud 201702786)
SV2018005610A (es) Derivados de oxopiridina sustituidos
CL2018003754A1 (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo.
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
BR112018010089A2 (pt) composições compreendendo cepas bacterianas
MD3209381T2 (ro) Compoziții care conțin tulpini bacteriene
CL2016002971A1 (es) Combinación.
CL2015003135A1 (es) Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimorficas y métodos de uso.
DK3297637T3 (da) Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
DK3542635T3 (da) Valleproteinbaseret yoghurtlignende produkt med højt proteinindhold, ingrediens egnet til fremstilling deraf og fremgangsmåde til fremstilling.
CL2015002897A1 (es) Inhibidores de bace1
CO2018013020A2 (es) Combinaciones farmacéuticas para el tratamiento del cáncer
DOP2017000111A (es) Inhibidor de cinasa aurora a
TR201901348T4 (tr) Metap-2 inhibitörleri olarak pirolidinon türevleri.
BR112017009265A2 (pt) apilimode para uso no tratamento do câncer colorretal
MX2018002416A (es) Derivados de 1,7-diaril-1,6-heptadien-3,5-diona, procedimiento para la preparación y uso de los mismos.
DK3275454T3 (da) Farmaceutisk sammensætning med silybin, ve og l-carnitin
CO2017009182A2 (es) Cepas bacterianas productoras de histamina para tratamiento del cáncer
DK3324938T3 (da) Topikale formuleringer og behandlinger
UY36173A (es) Metodo de tratamiento de enfermedades relacionadas con el factor inducible por hipoxia
BR112017005272A2 (pt) uso de cisteamina no tratamento de infecções causadas por leveduras/bolores
DK3383872T3 (da) 1,3,4-thiadiazolforbindelser og anvendelse deraf i cancerbehandling
PH12017500602A1 (en) Methods for treating ocular conditions

Legal Events

Date Code Title Description
FB Suspension of granting procedure